// App-Quantinova.ai

113 : Patterns of Biologics Use among Women with Autoimmune Disease Before, During, and After Pregnancy: A Population-based Study

Researchers

Presenter

  • Larry Lynd

Principal Investigators

  • Carlo Marra

  • Mary De Vera

Medical Centers

  • Memorial University of Newfoundland/University of British Columbia, St. Johns,Canada

  • University of British Columbia Faculty of Medicine, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Multiple Sclerosis

  • Ulcerative colitis

  • Inflammatory Arthritis

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • Certolizumab pegol

  • Tocilizumab

  • Natalizumab

  • Ustekinumab

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • Abatacept

  • Alefacept

  • Belimumab

  • golimumab

  • Rituximab

  • Anakinra

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim